CTRI/2025/01/079638已完成Unknown
An In-Vivo Study to Determine the Sun Protection Factor of Be Bodywise Lightest Mineral Sunscreen SPF50 plus.
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Change in Individual MED (iMED) score
研究概览
简要总结
This is the invivo SPF test done as per ISO 24444 to determine the SPF
Test Product:
| Be Bodywise Lightest Mineral Sunscreen SPF50+ |
Done on 10 human volunteers.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Individual should have ITA angle in the range of 18 t0 40, 41 to 55, and greater than 56
- •Individuals free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator.
- •Individuals who have completed a preliminary medical history evaluation.
- •Individuals who have read, understood and signed an informed consent document relating to the specific study to which they are subscribing.
- •Individuals with no known abnormal response to sunlight.
排除标准
- •1.Individuals taking medication which in the opinion of the investigator would mask or interfere with the results.
- •2.Individuals with chronic skin allergies.
- •3.Individuals with suntan or sunburn.
- •4.Individuals with abnormal reaction to the sun.
- •5.Pregnant or lactating females.
- •6.Subjects accustomed to using sun beds.
- •7.Subjects who have participated in an SPF study within the last two months.
结局指标
主要结局
Change in Individual MED (iMED) score
时间窗: Day1, Day2
次要结局
- Change in the redness of skin(Delayed Erythema Response)
研究者
Dr Robin Chugh
CCFT Laboratories
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Study is designed to assess the safety and tolerability of ceralasertib at increasing doses in combination with other anti-cancer treatment in patients with advanced tumours2023-505006-41-00AstraZeneca AB100
招募中
1 期
Phase IB Study to Assess the Safety, Tolerability and Efficacy of PM14 in combination with Atezolizumab in Pretreated Patients with Selected Advanced Solid Tumors2023-509688-25-00Pharma Mar S.A.50
招募中
4 期
The Effectiveness of Topical Silicone Application Combined With Photoprotection in the Development of Scarring Following BlepharoplastyNCT07387536Instituto de Oftalmología Fundación Conde de Valenciana30
已完成
1 期
A study to investigate the safety, tolerability, pharmacokinetics, and early signs of biological activity of danegaptide following oral administration in participants with diabetic macular edema2023-503683-16-00Breye Therapeutics ApS3
招募中
2 期
Phase I/II study to determine the safety and efficacy of Ribociclib in combination with hormone therapy and hypofractionated radiotherapy in breast cancer, with positive hormone receptors and negative HER2 status, in newly diagnosed, not immediately operable (or wishing to avoid surgery), elderly patientbreast cancer2022-501527-24-00Centre Antoine Lacassagne85